Helping you keep track of the latest market developments and challenges in this rapidly evolving and essential segment of the insurance industry.
Some of this year’s survey results are particularly encouraging. For example:
This year, we are also pleased to provide the key raw survey data, increasing transparency and widening the potential for extended use and analysis across the industry.
Costing hundreds of thousands, even millions of dollars per individual, several immuno- and gene therapies have been approved to-date. Usage expansion of such therapies is […]
Since early April 2020, COVID-19 disease (virus ‘SARS-CoV-2’) has become the leading cause of death in the United States, outpacing cancer and cardiovascular disease in […]